[Pharmacological properties of a combination of the antirheumatic drug Benetazone (trimetazone) and the analgesic drug dextropropoxyphene].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use* / Q000633:toxicity; D011431:Dextropropoxyphene / Q000627:therapeutic use* / Q000633:toxicity; D004338:Drug Combinations; D004487:Edema / Q000188:drug therapy; D005260:Female; D011720:Pyrazoles / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D011720:Pyrazoles; D011431:Dextropropoxyphene
Farmakologické vlastnosti kombinace antirevmatika benetazonu a analgetika dextropropoxyfenu